UnitedHealth Group (NYSE:UNH) released its quarterly earnings results on Wednesday. The healthcare conglomerate reported $3.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.98 by $0.53, RTT News reports. The business had revenue of $65.12 billion for the quarter, compared to the consensus estimate of $63.97 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $3.88 earnings per share. UnitedHealth Group updated its FY 2020
Pre-Market guidance to 16.50-16.75 EPS and its FY20 guidance to $16.50-16.75 EPS.
Shares of UNH opened at $331.42 on Wednesday. The company has a 50-day simple moving average of $310.40 and a two-hundred day simple moving average of $296.46. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.84 and a quick ratio of 0.84. The firm has a market capitalization of $314.96 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 1.44 and a beta of 0.68. UnitedHealth Group has a one year low of $187.72 and a one year high of $333.70.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date was Friday, September 11th. UnitedHealth Group’s payout ratio is currently 33.09%.
In other UnitedHealth Group news, EVP Marianne D. Short sold 12,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $321.34, for a total value of $3,856,080.00. Following the completion of the transaction, the executive vice president now owns 140,885 shares in the company, valued at $45,271,985.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Stephen J. Hemsley sold 59,012 shares of the firm’s stock in a transaction on Thursday, July 16th. The shares were sold at an average price of $307.04, for a total value of $18,119,044.48. Following the transaction, the director now directly owns 909,059 shares of the company’s stock, valued at approximately $279,117,475.36. The disclosure for this sale can be found here. Insiders have sold a total of 128,522 shares of company stock worth $39,886,448 in the last quarter. Company insiders own 0.80% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: The Discount Rate – What You Need to Know
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.